Felix Mahfoud Selected Research

Denervation

12/2022	Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation.
6/2022	Renal denervation prevents subclinical atrial fibrillation in patients with hypertensive heart disease: Randomized, sham-controlled trial.
1/2022	Arterial hypertension - clinical trials update 2022.
1/2022	Renal Artery Variations in Patients With Mild-to-Moderate Hypertension From the RADIANCE-HTN SOLO Trial.
1/2022	Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
1/2022	Arterial hypertension - Clinical trials update 2021.
1/2022	Renal denervation reduces atrial remodeling in hypertensive rats with metabolic syndrome.
1/2022	Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
12/2021	Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trial.
4/2021	Prioritised endpoints for device-based hypertension trials: the win ratio methodology.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felix Mahfoud Research Topics

Disease

142	Hypertension (High Blood Pressure) 12/2022 - 01/2010
32	Heart Failure 04/2022 - 01/2010
13	Atrial Fibrillation 06/2022 - 07/2012
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2010
8	Myocardial Infarction 07/2022 - 01/2010
8	Fibrosis (Cirrhosis) 01/2022 - 09/2012
8	Hemorrhage 01/2022 - 03/2014
7	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 04/2012
7	Chronic Renal Insufficiency 07/2022 - 08/2013
6	Stroke (Strokes) 01/2022 - 12/2015
5	Death (Near-Death Experience) 07/2022 - 04/2011
5	Inflammation (Inflammations) 01/2022 - 02/2015
5	Myocarditis (Carditis) 01/2019 - 08/2010
5	Sleep Apnea Syndromes (Sleep Apnea) 01/2017 - 07/2012
4	Atrial Remodeling 01/2022 - 01/2013
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 10/2013
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2011
4	Essential Hypertension 01/2018 - 12/2011
4	Obstructive Sleep Apnea 01/2017 - 07/2012
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 02/2012
3	Thrombosis (Thrombus) 07/2020 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 12/2013
3	Isolated Systolic Hypertension 01/2017 - 01/2015
3	Ventricular Tachycardia 10/2016 - 01/2012
3	Systolic Heart Failure 02/2016 - 09/2013
3	Insulin Resistance 12/2011 - 05/2011
2	Heart Diseases (Heart Disease) 06/2022 - 02/2012
2	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 01/2022
2	Ischemia 04/2022 - 10/2013
2	Hypotension (Low Blood Pressure) 01/2022 - 01/2021
2	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2011
2	Hypertrophy 01/2022 - 06/2014
2	False Aneurysm (Pseudoaneurysm) 01/2021 - 10/2011
2	Headache (Headaches) 10/2019 - 10/2013
2	Glucose Intolerance 07/2017 - 08/2013
2	Obesity 01/2017 - 12/2011
2	Hypoxia (Hypoxemia) 08/2016 - 10/2013
2	Ventricular Fibrillation 06/2015 - 10/2013
2	Metabolic Diseases (Metabolic Disease) 07/2014 - 05/2013
2	Albuminuria 05/2014 - 09/2012
2	Diabetes Mellitus 09/2013 - 08/2013
2	Chronic Disease (Chronic Diseases) 08/2013 - 11/2010
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 05/2013 - 03/2012
1	Diabetic Nephropathies (Diabetic Nephropathy) 04/2022
1	Coronary Disease (Coronary Heart Disease) 04/2022

Drug/Important Bio-Agent (IBA)

42	Antihypertensive Agents (Antihypertensives)IBA 12/2022 - 10/2011
21	salicylhydroxamic acid (SHAM)IBA 06/2022 - 10/2013
13	Pharmaceutical PreparationsIBA 07/2022 - 01/2014
11	DiureticsIBA 06/2022 - 10/2011
9	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 05/2011
6	Ramipril (Altace)FDA LinkGeneric 01/2021 - 12/2015
5	omega-Chloroacetophenone (Mace)IBA 07/2022 - 01/2018
5	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2010
5	Telmisartan (Micardis)FDA Link 01/2021 - 06/2017
4	SodiumIBA 04/2022 - 09/2013
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2015 - 01/2010
3	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2022 - 01/2020
3	empagliflozinIBA 01/2022 - 01/2020
3	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2010
3	PolymersIBA 10/2021 - 01/2019
3	AnticoagulantsIBA 10/2021 - 03/2014
3	pro-brain natriuretic peptide (1-76)IBA 08/2019 - 09/2014
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016 - 05/2013
3	ReninIBA 12/2015 - 09/2013
2	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 07/2017
2	CreatinineIBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 01/2018
2	SaltsIBA 01/2022 - 10/2011
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 10/2021 - 01/2019
2	AlbuminsIBA 01/2021 - 09/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 04/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 03/2014
2	Anti-Arrhythmia AgentsIBA 01/2018 - 10/2016
2	Atenolol (Tenormin)FDA LinkGeneric 08/2016 - 07/2012
2	IvabradineIBA 02/2016 - 01/2016
2	AldosteroneIBA 01/2016 - 12/2015
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2015 - 01/2010
2	C-Reactive ProteinIBA 02/2015 - 11/2010
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2013 - 07/2012
1	Syntex adjuvant formulationIBA 06/2022
1	Mineralocorticoid Receptor AntagonistsIBA 04/2022
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 04/2022
1	dapagliflozinIBA 04/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022

Therapy/Procedure

111	Denervation 12/2022 - 05/2011
50	Therapeutics 02/2022 - 01/2010
45	Catheters 06/2022 - 05/2011
41	Sympathectomy (Sympathectomies) 10/2020 - 05/2011
6	Stents 10/2021 - 01/2018
5	Drug Therapy (Chemotherapy) 02/2022 - 05/2013
4	Catheter Ablation 01/2021 - 10/2011
4	Electrodes (Electrode) 01/2021 - 04/2015
3	Percutaneous Coronary Intervention 01/2022 - 04/2012
3	Heart Transplantation (Grafting, Heart) 09/2014 - 04/2011
3	Radiofrequency Ablation 02/2014 - 12/2011
2	Drug-Eluting Stents 07/2022 - 04/2020
2	Transcatheter Aortic Valve Replacement 04/2022 - 03/2021
2	Aftercare (After-Treatment) 11/2013 - 05/2011
1	Kidney Transplantation 04/2022